Studies have shown that expression of GLUT1 and HK-II in epithelial cancer cells, including breast, esophageal, and lung cancer cells, plays a pivotal role in glucose metabolism and that the expression levels of GLUT1 and HK-II are correlated with malignancy (Tsukada et al. 2012). Here, SLC2A1 is linked to lung carcinoma.